Hydrocephalus Shunt Market By Shunt Type (Ventriculo-Peritoneal Shunt, Ventriculo-Atrial Shunt, Lumboperitoneal Shunt, Others), By Application (Post-Traumatic Hydrocephalus, Tumor-Related Hydrocephalus, Infection-Related Hydrocephalus, Congenital Hydrocephalus, Others), By Technology (Programmable Shunts, Non-Programmable Shunts), By Age Group (Pediatric, Adult, Geriatric), and By End-User (Hospitals, Specialized Neurosurgery Centers, Rehabilitation Centers, Ambulatory Surgical Centers, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Report Coverage:

By Shunt Type

• Ventriculo-Peritoneal Shunt
• Ventriculo-Atrial Shunt
• Lumboperitoneal Shunt
• Others

By Application

• Post-Traumatic Hydrocephalus
• Tumor-Related Hydrocephalus
• Infection-Related Hydrocephalus
• Congenital Hydrocephalus
• Others

By Technology

• Programmable Shunts
• Non-Programmable Shunts

By Age Group

• Pediatric
• Adult
• Geriatric

By End-User

• Hospitals
• Specialized Neurosurgery Centers
• Rehabilitation Centers
• Ambulatory Surgical Centers
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Medtronic
• Integra LifeSciences
• Aesculap, Inc.
• Stryker Corporation
• Sophysa
• B. Braun Melsungen AG
• Codman & Shurtleff, Inc.
• DePuy Synthes
• NuVasive, Inc.
• Zimmer Biomet
• MicroPort Scientific Corporation
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Natus Medical Incorporated
• Abbott Laboratories
• Terumo Corporation